All News

Expansive (full read) review of CBD - legal and regulatory overview, availability, physiologic and pharmacologic effects, safety, & risks, standards, use in specific rheumatic disorders. https://t.co/hefwKTmPLK https://t.co/IZKZMOZ5ij

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast square

RheumNow Podcast – What You Do For & What You Do To the Patient (4.8.2022)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week and discusses the use of fibroscan in RA, steroid hip injections in OA and famous quotes from a famous cardiologist.

Read Article
Depression was studied in 208 #PSA patients - Depression was found in 30%. Depression risk was higher in those with higher disease activity (DAPSA; P=.007) and functional impairment (HAQ-DI; p=-.02) https://t.co/0bZ2xPprTp https://t.co/Gdiic5iKCi

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast square

PsA All the Way – Unmet Needs

d Jack Cush, MD

Throughout the month of April 2022, RheumNow is introducing a new approach to education and information sharing – a campaign devoted to a single disease. Our first campaign is entitled PsA All the Way: RheumNow will escalate awareness on this topic, its unmet needs, clarify advances and discuss key advances and modern disease management. We're featuring guest bloggers, hosting Tuesday Night Rheumatology, posting slides and videos, and much more dedicated to PsA.

Read Article
Do you discuss/screen for depression with your patients when discussing pain and fatigue? #RNL2022 @RheumNow

Dr. Rachel Tate uptoTate ( View Tweet)

RheumNow Podcast square

Hand OA and Heroes in Rheumatology (2.11.2022)

d Jack Cush, MD

Interesting reports this week about dementia, who gets hand OA and a great list of women Heroes and Pillars of Rheumatology. Tune in as Dr. Jack Cush reviews the news and journal articles from this past week in RheumNow.com.

Read Article
RheumNow Podcast square

Indications Awaiting (12.17.21)

d Jack Cush, MD

There's good news and bad news in rheumatology fellowship matching for 2022.  There's also new FDA approvals and indications, but a new serious safety warning has arisen from the CDC about the J&J COVID-19 vaccine. 

Dr. Jack Cush reviews the latest news, journal reports, regulatory approvals, plus 3 new cases from rheumatologists.

Read Article
Tofacitinib 1st JAK Inhibitor Approved for Ankylosing Spondylitis The FDA approved tofacitinib (Xeljanz, Xeljanz XR) for treating active ankylosing spondylitis in adults, Pfizer announced. https://t.co/NczbrBXBl7 https://t.co/l93OM86qaX

Links:

Dr. John Cush RheumNow ( View Tweet)
RA.Ow02.jpg

Better assessment and management of multimorbidity

d Mrinalini Dey, MD

Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors. 

Read Article
brain.mri2_.jpg

Cognitive Impairment in Patients with Rheumatoid Arthritis

d Akhil Sood, MD

Evidence suggests that RA patients are at increased risk for cognitive impairment. This is likely mediated by certain factors, including chronic inflammation and accelerated atherosclerosis. In the clinical setting, it is important to identify RA patients at increased risk for cognitive impairment.

Read Article
Dementia is ⬆️in #RheumatoidArthritis says Elena Myasoedva but #RA has more DM &CV disease which ⬆️dementia. Need to separate vascular dementia from Alzheimer’s. When I trained we thought less dementia in RA -likely not true. More work is coming. 9T213 aging hub #ACR21 @RheumNow

Janet Pope Janetbirdope ( View Tweet)

#Depression is associated with a 3x increased mortality risk in patients with incident #RA. 👉🏼Results from #DANBIO 👉🏼~11000 RA pts, ~1000 starting antidepressants Abs#1659 #ACR21 @RheumNow https://t.co/SsEjmLzacP https://t.co/1GiFE0KLjK

Links:

Mrinalini Dey DrMiniDey ( View Tweet)
#ACR21 Ab#1036. Rheum is often the field of uncertainty. @zach_wallace_md shows uncertainty correlates w/ depression, anxiety, sickness impact across rheum diseases ⭐️Is uncertainty something to target as intervention? @Rheumnow https://t.co/v9kbk2hCqO https://t.co/50ELS3ZQp9

Links:

Eric Dein ericdeinmd ( View Tweet)
@Sineadm15 @bososhea on undiagnosed depression in axSpA. Common, and associated with worse disease activity and quality of life. Abstr#1305 #ACR21 @RheumNow https://t.co/PBH1F3XEGv
Richard Conway RichardPAConway ( View Tweet)
My video take from yesterday for @RheumNow: 'Tired of Doing Nothing About Fatigue' #ACR21 https://t.co/EXjOibL5s9 https://t.co/cR6r8GdDor

Links:

David Liew drdavidliew ( View Tweet)

My video take from yesterday for @RheumNow: 'Tired of Doing Nothing About Fatigue' #ACR21 https://t.co/EXjOibL5s9 https://t.co/cR6r8GdDor

Links:

David Liew drdavidliew ( View Tweet)

RA.Ow02.jpg

Towards better assessment and management of multimorbidity

d Mrinalini Dey, MD

Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors. 

Read Article
HCP #burnout coping strategies listed during 6S228 Let’s talk about mental health #ACR21 - writing, yoga, exercise, gardening, drawing& other creativity. I practice gratitude 🙏🏻 @RheumNow Burnout is real and magnified by #COVID19 pressures https://t.co/PUklM2Ci6e
Janet Pope Janetbirdope ( View Tweet)
3/4 axSpA EMAS pts had/perceived to have employment challenge. Poor physical/mental health, lower education, hx job change due to axSpA associated w/difficulties/perceived difficulties. Earlier dx/rx AND advocacy needed. Abs 0366 #ACR21 #RheumNow @RheumNow https://t.co/dlGhOymxVQ https://t.co/CWD6U1vRE0

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
#ACR21 Abst#0284. RA and Dementia? ⭐️1366 pts with RA, retro pop-based cohort ⭐️Risks: older age, diabetes, CVD. ⭐️Large joint swelling swelling HR 2.2 (1.2-3.9). No significance by RF/CCP/ESR/erosions/nodules ▶️CVD risks appear > RA activity https://t.co/2uN2lBs4tr @Rheumnow https://t.co/HEOXPosE5Z

Links:

Eric Dein ericdeinmd ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×